This trial will assess whether or not Stellate Ganglion Block (SGB), a treatment established to relieve pain, can also help reduce the symptoms of Posttraumatic Stress Disorder (PTSD).
2 Primary · 1 Secondary · Reporting Duration: 8 weeks after SGB, Sham, or WLC enrollment
360 Total Participants · 3 Treatment Groups
Primary Treatment: SGB · Has Placebo Group · N/A
Age 18 - 55 · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|William S. Middleton Memorial Veterans Hospital, Madison, WI||100.0%|